1.Date of the resolution of the board of directors or
shareholders meeting:2025/03/12
2.Content of the investment plan:Establishing a new GLP-1 production line
at our company.
3.Projected monetary amount of the investment:NT$1.6 billion
4.Projected date of the investment:2025~2027
5.Source of capital funds:Operating capital
6.Specific purpose:Our company plans to expand our business by establishing
a new GLP-1(glucagon-like peptide-1) production line, which is expected to
be completed in 2027.
7.Any other matters that need to be specified:None